The overall risk of incident MetS increased by 13% (RR: 1.13; 95% CI: 1.11–1.16) per 5 U/l of ALT increment with significant heterogeneity (I2 = 53.4%, P = 0.045). Here, GPT is linked to metabolic syndrome.